1. CLSI.

Reference method for broth dilution antifungal susceptibility testing of yeasts.

Approved Standard- Third Edition. CLSI document M27-A3.
Wayne, PA: Clinical and Laboratory Standards institute; 2008.
2. CLSI.
Reference method for broth dilution antifungal susceptibility testing of yeasts.
4th ed. CLSI standard M27.
Wayne, PA: Clinical and Laboratory Standards institute; 2017.
3. CLSI.
Reference method for broth dilution antifungal susceptibility testing of yeasts.
1st ed. CLSI supplement M60.
Wayne, PA: Clinical and Laboratory Standards institute; 2017.
4. CLSI.
Method for antifungal disk diffusion susceptibility testing of yeasts. 3rd edition.
CLSI guideline M44.
Wayne, PA: Clinical and Laboratory Standards institute; 2018.
5. CLSI.
Reference method for broth dilution antifungal susceptibility testing of yeasts.
2nd edition. CLSI supplement M60.
Wayne, PA: Clinical and Laboratory Standards institute; 2020.
6. CLSI.
Reference method for broth dilution antifungal susceptibility testing of
filamentous fungi; Approved Standard-Second edition. CLSI document M38-A2.
Wayne, PA: Clinical and Laboratory Standards institute; 2008.
7. CLSI.
Reference method for broth dilution antifungal susceptibility testing of
filamentous fungi; 3rd edition. CLSI stansard M38.
Wayne, PA: Clinical and Laboratory Standards institute; 2017.
8. CLSI.
Performance Standards for Antifungal Susceptibility Testing of Filamentous
Fungi; 1st edition. CLSI supplement M61.
Wayne, PA: Clinical and Laboratory Standards institute; 2017.
9. CLSI.
Performance standards for antifungal susceptibility testing of filamentous
fungi; 2nd edition. CLSI supplement M61.
Wayne, PA: Clinical and Laboratory Standards institute; 2020.
10. Amona FM, Denning DW, Moukassa D, Hennequin C.
Current burden of serious fungal infections in Republic of Congo.
Mycoses 2020;63:543-52.
11. Brown L, Leck AK, Gichangi M, Burton MJ, Denning DW.
The global incidence and diagnosis of fungal keratitis.
Lancet Infect Dis 2021;21:e49-e57.
12. Walkden A, Fullwood C, Tan SZ, Au L, Armstrong M, Brahma AK, et al.
Association between season, temperature and causative organism in microbial
keratitis in the UK.
Cornea 2018;37:1555-60.
13. Tan SZ, Walkden A, Au L, Fullwood C, Hamilton A, Qamruddin A, et al.
Twelve-year analysis of microbial keratitis trends at a UK tertiary hospital.
Eye (Lond) 2017;31:1229-36.
14. Ting DSJ, Ho CS, Deshmukh R, Said DG, Dua HS.
Infectious keratitis: an update on epidemiology, causative microorganisms, risk
factors, and antimicrobial resistance.
Eye (Lond) 2021;35:1084-101.
15. Bongomin F, Gago S, Oladele RO, Denning DW.
Global and multi-national prevalence of fungal diseases-estimate precision.
J Fungi (Basel) 2017;3:57.
16. Cen Y, Li Y, Huang C, Wang W.
Bibliometric and visualized analysis of global research on fungal keratitis from
1959 to 2019.
Medicine (Baltimore) 2020;99:e20420.
17. Hung N, Yeh LK, Ma DH, Lin HC, Tan HY, Chen HC, et al.
Filamentous Fungal Keratitis in Taiwan: Based on Molecular Diagnosis.
Transl Vis Sci Technol 2020;9:32.
18. Shah A, Sachdev A, Coggon D, Hossain P.
Geographic variations in microbial keratitis: an analysis of the peer-reviewed
literature.
Br J Ophthalmol 2011;95:762-7.
19. Gaujoux T, Borsali E, Goldschmidt P, Chaumeil C, Baudouin C, Nordmann
JP, et al.
Fungal keratitis in France.
Acta Ophthalmol 2011;89:e215-6.
20. Fekih O, Haj Said O, Zgolli HM, Mabrouk S, Bakir K, Nacef L.
Microbiologic profile of the mycosic absess on a reference center in Tunisia.
Tunis Med 2019;97:644-9.
21. Benadada S.
Les kératites fongiques : Aspects cliniques et thérapeutiques à propos de 30 cas
au Service d’Ophtalmologie A [Thèse].
Rabat: Université Mohamed V, Faculté de Médecine et de Pharmacie; 2017.
22. Laatfa I.
Les kératites fongiques : Problèmes diagnostiques thérapeutiques et profils
évolutifs (à propos de 21 cas) [Thèse].
Fès: Université Sidi Mohamed Ben Abdallah, Faculté de Médecine; 2019.
23. Green M, Carnt N, Apel A, Stapleton F.
Queensland microbial keratitis database: 2005-2015.
Br J Ophthalmol 2019;103:1481-6.
24. Chowdhary A, Singh K.
Spectrum of fungal keratitis in North India.
Cornea 2005;24:8-15.
25. Thomas PA, Kaliamurthy J.
Mycotic keratitis: epidemiology, diagnosis and management.
Clin Microbiol Infect 2013;19:210-20.
26. Ibrahim MM, de Angelis R, Lima AS, Viana de Carvalho GD, Ibrahim FM,
Malki LT, et al.
A new method to predict the epidemiology of fungal keratitis by monitoring the
sales distribution of antifungal eye drops in Brazil.
PLoS One 2012;7:e33775.
27. Wilhelmus KR.
Climatology of dematiaceous fungal keratitis.
Am J Ophthalmol 2005;140:1156-7.
28. Bourcier T, Thomas F, Borderie V, Chaumeil C, Laroche L.
Bacterial keratitis: predisposing factors, clinical and microbiological review of
300 cases.
Br J Ophthalmol 2003;87:834-8.
29. Bharathi MJ, Ramakrishnan R, Vasu S, Meenakshi R, Palaniappan R.
Epidemiological characteristics and laboratory diagnosis of fungal keratitis. A
three-year study.
Indian J Ophthalmol 2003;51:315-21.
30. Karthikeyan RS, Leal SM, Prajna NV, Dharmalingam K, Geiser DM,
Pearlman E, et al.
Expression of innate and adaptive immune mediators in human corneal tissue
infected with Aspergillus or fusarium.
J Infect Dis 2011;204:942-50.
31. Khoo P, Cabrera-Aguas MP, Nguyen V, Lahra MM, Watson SL.
Microbial keratitis in Sydney, Australia: risk factors, patient outcomes, and
seasonal variation.
Graefes Arch Clin Exp Ophthalmol 2020;258:1745-55.
32. Nowik KE, Wylęgała A, Nowik K, Wylęgała E.
A single-centre retrospective observational study of fungal keratitis in Poland
with a review of findings in Europe.
Ann Agric Environ Med 2020;27:343-7.
33. Hoarau G, Albrieux M, Martin-Phipps T, Zitte-Zehler K, Borry L, Peytral J,
et al.
Kératites fongiques : étude rétrospective monocentrique sur 5ans à l’île de la
Réunion.
J Fr Ophtalmol 2018;41:321-5.
34. Xie L, Zhong W, Shi W, Sun S.
Spectrum of fungal keratitis in north China.
Ophthalmology 2006;113:1943-8.
35. Ghosh A, Kaur H, Gupta A, Singh S, Rudramurthy SM, Gupta S, et al.
Emerging dematiaceous and hyaline fungi causing keratitis in a tertiary care
centre from North India.
Cornea 2020;39:868-76.
36. Upadhyay MP, Karmacharya PC, Koirala S, Shah DN, Shakya S, Shrestha JK,
et al.
The Bhaktapur eye study: ocular trauma and antibiotic prophylaxis for the
prevention of corneal ulceration in Nepal.
Br J Ophthalmol 2001;85:388-92.
37. Ganguly S, Salma KC, Kansakar I, Sharma M, Bastola P, Pradhan R.
Pattern of fungal isolates in cases of corneal ulcer in the western periphery of
Nepal.
Nepal J Ophthalmol 2011;3:118-22.
38. Verghese S.
Post traumatic fungal keratitis caused by Acremonium recifei.
Indian J Pathol Microbiol 2010;53:587-8.
39. Cho CH, Lee SB.
Clinical analysis of microbiologically proven fungal keratitis according to prior
topical steroid use: a retrospective study in South Korea.
BMC Ophthalmol 2019;19:207.
40. Yildiz EH, Abdalla YF, Elsahn AF, Rapuano CJ, Hammersmith KM, Laibson
PR, et al.
Update on fungal keratitis from 1999 to 2008.
Cornea 2010;29:1406-11.
41. Rondeau N, Bourcier T, Chaumeil C, Borderie V, Touzeau O, Scat Y, et al.
Les kératomycoses au Centre Hospitalier National d'Ophtalmologie des Quinze-
Vingts.
J Fr Ophtalmol 2002;25:890-6.
42. Khor WB, Aung T, Saw SM, Wong TY, Tambyah PA, Tan AL, et al.
An outbreak of Fusarium keratitis associated with contact lens wear in
Singapore.
JAMA 2006;295:2867-73.
43. Chang DC, Grant GB, O'Donnell K, Wannemuehler KA, Noble-Wang J, Rao
CY, et al.
Multistate outbreak of Fusarium keratitis associated with use of a contact lens
solution.
JAMA 2006;296:953-63.
44. Singh G, Palanisamy M, Madhavan B, Rajaraman R, Narendran K, Kour A,
et al.
Multivariate analysis of childhood microbial keratitis in South India.
Ann Acad Med Singap 2006;35:185-9.
45. Singh M, Gour A, Gandhi A, Mathur U, Farooqui JH.
Demographic details, risk factors, microbiological profile, and clinical outcomes
of pediatric infectious keratitis cases in North India.
Indian J Ophthalmol 2020;68:434-40.
46. Farrell S, McElnea E, Moran S, Knowles S, Murphy CC.
Fungal keratitis in the Republic of Ireland.
Eye (Lond) 2017;31:1427-34.
47. Khor WB, Prajna VN, Garg P, Mehta JS, Xie L, Liu Z, et al.
The Asia cornea society infectious keratitis study: a prospective multicenter
study of infectious keratitis in Asia.
Am J Ophthalmol 2018;195:161-70.
48. Bharathi MJ, Ramakrishnan R, Meenakshi R, Shivakumar C, Raj DL.
Analysis of the risk factors predisposing to fungal, bacterial & Acanthamoeba
keratitis in south India.
Indian J Med Res 2009;130:749-57.
49. Whitcher JP, Srinivasan M, Upadhyay MP.
Corneal blindness: a global perspective.
Bull World Health Organ 2001;79:214-21.
50. Stapleton F.
The epidemiology of infectious keratitis.
Ocul Surf 2021 Aug 19. [Online ahead of print]
51. Srinivasan M.
Fungal keratitis.
Curr Opin Ophthalmol 2004;15:321-7.
52. Dan J, Zhou Q, Zhai H, Cheng J, Wan L, Ge C, et al.
Clinical analysis of fungal keratitis in patients with and without diabetes.
PLoS One 2018;13:e0196741.
53. St Leger AJ, Desai JV, Drummond RA, Kugadas A, Almaghrabi F, Silver P, et
al.
An ocular commensal protects against corneal infection by driving an
interleukin-17 response from mucosal γδ T cells.
Immunity 2017;47:148-58.
54. Bourcier T, Sauer A, Dory A, Denis J, Sabou M.
Fungal keratitis.
J Fr Ophtalmol 2017;40:e307-e13.
55. Wong RL, Gangwani RA, Yu LW, Lai JS.
New treatments for bacterial keratitis.
J Ophthalmol 2012;2012:831502.
56. Keay LJ, Gower EW, Iovieno A, Oechsler RA, Alfonso EC, Matoba A, et al.
Clinical and microbiological characteristics of fungal keratitis in the United
States, 2001-2007: a multicenter study.
Ophthalmology 2011;118:920-6.
57. Lakhundi S, Siddiqui R, Khan NA.
Pathogenesis of microbial keratitis.
Microb Pathog 2017;104:97-109.
58. Gopinathan U, Sharma S, Garg P, Rao GN.
Review of epidemiological features, microbiological diagnosis and treatment
outcome of microbial keratitis: experience of over a decade.
Indian J Ophthalmol 2009;57:273-9.
59. Nath R, Baruah S, Saikia L, Devi B, Borthakur AK, Mahanta J.
Mycotic corneal ulcers in upper Assam.
Indian J Ophthalmol 2011;59:367-71.
60. Cruz OA, Sabir SM, Capo H, Alfonso EC.
Microbial keratitis in childhood.
Ophthalmology 1993;100:192-6.
61. Ormerod LD, Hertzmark E, Gomez DS, Stabiner RG, Schanzlin DJ, Smith RE.
Epidemiology of microbial keratitis in southern California. A multivariate
analysis.
Ophthalmology 1987;94:1322-33.
62. Tanure MA, Cohen EJ, Sudesh S, Rapuano CJ, Laibson PR.
Spectrum of fungal keratitis at Wills Eye Hospital, Philadelphia, Pennsylvania.
Cornea 2000;19:307-12.
63. Bharathi MJ, Ramakrishnan R, Meenakshi R, Padmavathy S, Shivakumar C,
Srinivasan M.
Microbial keratitis in South India: influence of risk factors, climate, and
geographical variation.
Ophthalmic Epidemiol 2007;14:61-9.
64. Ramesh S, Ramakrishnan R, Bharathi MJ, Amuthan M, Viswanathan S.
Prevalence of bacterial pathogens causing ocular infections in South India.
Indian J Pathol Microbiol 2010;53:281-6.
65. Gong Y, Xin M.
Incidence of recurrent fungal keratitis after primary keratoplasty and visual
outcome and prognosis after intervention for the recurrence.
Medicine (Baltimore) 2019;98:e15910.
66. Rogers GM, Goins KM, Sutphin JE, Kitzmann AS, Wagoner MD.
Outcomes of treatment of fungal keratitis at the University of Iowa Hospitals
and Clinics: a 10-year retrospective analysis.
Cornea 2013;32:1131-6.
67. Mathes KJ, Tran KD, Mayko ZM, Stoeger CG, Straiko MD, Terry MA.
Reports of post-keratoplasty infections for eye bank-prepared and non-eye
bank-prepared Corneas: 12 years of data from a single eye bank.
Cornea 2019;38:263-7.
68. Vinod Mootha V, Shahinpoor P, Sutton DA, Xin L, Najafzadeh MJ, de Hoog
GS.
Identification problems with sterile fungi, illustrated by a keratitis due to a non-
sporulating Chaetomium-like species.
Med Mycol 2012;50:361-7.
69. Cunha AM, Loja JT, Torrão L, Moreira R, Pinheiro D, Falcão-Reis F, et al.
A 10-year retrospective clinical analysis of fungal keratitis in a Portuguese
tertiary centre.
Clin Ophthalmol 2020;14:3833-9.
70. Qiao GL, Ling J, Wong T, Yeung SN, Iovieno A.
Candida Keratitis: epidemiology, management, and clinical outcomes.
Cornea 2020;39:801-5.
71. Cheikhrouhou F, Makni F, Neji S, Trigui A, Sellami H, Trabelsi H, et al.
Epidemiological profile of fungal keratitis in Sfax (Tunisia).
J Mycol Med 2014;24:308-12.
72. Periman LM, Harrison DA, Kim J.
Fungal keratitis after photorefractive keratectomy: delayed diagnosis and
treatment in a co-managed setting.
J Refract Surg 2003;19:364-6.
73. Verma S, Tuft SJ.
Fusarium solani keratitis following LASIK for myopia.
Br J Ophthalmol 2002;86:1190-1.
74. Sauer A, Abry F, Lhermitte B, Candolfi E, Speeg-Schatz C, Bourcier T.
Fonte purulente de la cornée secondaire à une infection à Fusarium oxysporum
polyrésistant favorisée par une corticothérapie topique.
J Fr Ophtalmol 2008;31:534.
75. Stern GA, Buttross M.
Use of corticosteroids in combination with antimicrobial drugs in the treatment
of infectious corneal disease.
Ophthalmology 1991;98:847-53.
76. Choi DM, Goldstein MH, Salierno A, Driebe WT.
Fungal keratitis in a daily disposable soft contact lens wearer.
CLAO J 2001;27:111-2.
77. Stapleton F, Carnt N.
Contact lens-related microbial keratitis: how have epidemiology and genetics
helped us with pathogenesis and prophylaxis.
Eye (Lond) 2012;26:185-93.
78. Hoffman JJ, Burton MJ, Leck A.
Mycotic keratitis-a global threat from the filamentous fungi.
J Fungi (Basel) 2021;7:273.
79. Bullock JD, Warwar RE, Elder BL, Khamis HJ.
Microbiological investigations of ReNu plastic bottles and the 2004 to 2006
ReNu with MoistureLoc-related worldwide Fusarium keratitis event.
Eye Contact Lens 2016;42:147-52.
80. Milner MS, Beckman KA, Luchs JI, Allen QB, Awdeh RM, Berdahl J, et al.
Dysfunctional tear syndrome: dry eye disease and associated tear film
disorders - new strategies for diagnosis and treatment.
Curr Opin Ophthalmol 2017;27:3-47.
81. Khoo P, Cabrera-Aguas M, Robaei D, Lahra MM, Watson S.
Microbial keratitis and ocular surface disease: a 5-year study of the
microbiology, risk factors and clinical outcomes in Sydney, Australia.
Curr Eye Res 2019;44:1195-202.
82. Ghosh AK, Gupta A, Rudramurthy SM, Paul S, Hallur VK, Chakrabarti A.
Fungal keratitis in North India: spectrum of agents, risk factors and treatment.
Mycopathologia 2016;181:843-50.
83. Mills B, Radhakrishnan N, Karthikeyan Rajapandian SG, Rameshkumar G,
Lalitha P, Prajna NV.
The role of fungi in fungal keratitis.
Exp Eye Res 2021;202:108372.
84. Burton MJ, Pithuwa J, Okello E, Afwamba I, Onyango JJ, Oates F, et al.
Microbial keratitis in East Africa: why are the outcomes so poor?
Ophthalmic Epidemiol 2011;18:158-63.
85. Fernandes M, Vira D, Dey M, Tanzin T, Kumar N, Sharma S.
Comparison between polymicrobial and fungal keratitis: clinical features, risk
factors, and outcome.
Am J Ophthalmol 2015;160:873-81.
86. Gopinathan U, Garg P, Fernandes M, Sharma S, Athmanathan S, Rao GN.
The epidemiological features and laboratory results of fungal keratitis: a 10-
year review at a referral eye care center in South India.
Cornea 2002;21:555-9.
87. Mahmoudi S, Masoomi A, Ahmadikia K, Tabatabaei SA, Soleimani M,
Rezaie S, et al.
Fungal keratitis: An overview of clinical and laboratory aspects.
Mycoses 2018;61:916-30.
88. Anane S, Ben Ayed N, Malek I, Chebbi A, Lejri S, Bouguila H, et al.
Les kératites fongiques dans la région de Tunis: caractéristiques
épidémiologiques, modalités diagnostiques et thérapeutiques.
Ann Biol Clin (Paris) 2010;68:441-7.
89. Chitamparam S, Lim TH, Tai E, Ibrahim M.
Mycotic Keratitis in a Tertiary Hospital in Northeastern Malaysia.
Turk J Ophthalmol 2020;50:332-8.
90. Amiel H, Chohan AB, Snibson GR, Vajpayee R.
Atypical fungal sclerokeratitis.
Cornea 2008;27:382-3.
91. Rosa RH, Miller D, Alfonso EC.
The changing spectrum of fungal keratitis in south Florida.
Ophthalmology 1994;101:1005-13.
92. Thomas PA, Leck AK, Myatt M.
Characteristic clinical features as an aid to the diagnosis of suppurative
keratitis caused by filamentous fungi.
Br J Ophthalmol 2005;89:1554-8.
93. Sun RL, Jones DB, Wilhelmus KR.
Clinical characteristics and outcome of Candida keratitis.
Am J Ophthalmol 2007;143:1043-5.
94. Karsten E, Watson SL, Foster LJ.
Diversity of microbial species implicated in keratitis: a review.
Open Ophthalmol J 2012;6:110-24.
95. Dalmon C, Porco TC, Lietman TM, Prajna NV, Prajna L, Das MR, et al.
The clinical differentiation of bacterial and fungal keratitis: a photographic
survey.
Invest Ophthalmol Vis Sci 2012;53:1787-91.
96. Wan L, Cheng J, Zhang J, Chen N, Gao Y, Xie LX.
Risk factors, treatment strategies, and outcomes of Endophthalmitis associated
with severe fungal keratitis.
Retina 2019;39:1076-82.
97. Thew MR, Todd B.
Fungal keratitis in far north Queensland, Australia.
Clin Exp Ophthalmol 2008;36:721-4.
98. Allan BD, Dart JK.
Strategies for the management of microbial keratitis.
Br J Ophthalmol. 1995;79:777-86.
99. Acharya M, Farooqui JH, Jain S, Mathur U.
Pearls and paradigms in Infective Keratitis.
Rom J Ophthalmol 2019;63:119-27.
100. Prajna NV, Mascarenhas J, Krishnan T, Reddy PR, Prajna L, Srinivasan M,
et al.
Comparison of natamycin and voriconazole for the treatment of fungal keratitis.
Arch Ophthalmol 2010;128:672-8.
101. Leck A.
Taking a corneal scrape and making a diagnosis.
Community Eye Health 2015;28:8-9.
102. Ansari Z, Miller D, Galor A.
Current thoughts in Fungal Keratitis: diagnosis and treatment.
Curr Fungal Infect Rep 2013;7:209-18.
103. Wang Y, Chen H, Xia T, Huang Y.
Characterization of fungal microbiota on normal ocular surface of humans.
Clin Microbiol Infect 2020;26:123.
104. Manikandan P, Varga J, Kocsubé S, Anita R, Revathi R, Németh TM, et al.
Epidemiology of Aspergillus keratitis at a tertiary care eye hospital in South
India and antifungal susceptibilities of the causative agents.
Mycoses 2013;56:26-33.
105. Rathi VM, Murthy SI, Mitra S, Yamjala B, Mohamed A, Sharma S.
Masked comparison of trypan blue stain and potassium hydroxide with
calcofluor white stain in the microscopic examination of corneal scrapings for
the diagnosis of microbial keratitis.
Indian J Ophthalmol 2021;69:2457-60.
106. Xie L, Dong X, Shi W.
Treatment of fungal keratitis by penetrating keratoplasty.
Br J Ophthalmol 2001;85:1070-4.
107. Omaima ES, Talaat O, Fikry EM, Adel H, Sahar M.
Mycotic eye infections in ophthalmic center, Mansoura University.
Egypt J Med Microbiol 2010;19:1-12.
108. Ishibashi Y, Kaufman HE.
Corneal biopsy in the diagnosis of keratomycosis.
Am J Ophthalmol 1986;101:288-93.
109. Zhang W, Yang H, Jiang L, Han L, Wang L.
Use of potassium hydroxide, Giemsa and calcofluor white staining techniques in
the microscopic evaluation of corneal scrapings for diagnosis of fungal keratitis.
J Int Med Res 2010;38:1961-7.
110. Chang HY, Chodosh J.
Diagnostic and therapeutic considerations in fungal keratitis.
Int Ophthalmol Clin 2011;51:33-42.
111. Palanisamy M, Dóczi I, Kocsubé S, Varga J, Tm N, Antal Z, et al.
Aspergillus species in human keratomycosis.
Wageningue: Wageningen Academic Publishers; 2008. p.293-328.
112. Manikandan P, Abdel-Hadi A, Randhir Babu Singh Y, Revathi R, Anita R,
Banawas S, et al.
Fungal Keratitis: Epidemiology, Rapid Detection, and Antifungal Susceptibilities
of Fusarium and Aspergillus Isolates from Corneal Scrapings.
Biomed Res Int. 2019;2019:6395840.
113. Badiee P, Nejabat M, Alborzi A, Keshavarz F, Shakiba E.
Comparative study of Gram stain, potassium hydroxide smear, culture and
nested PCR in the diagnosis of fungal keratitis.
Ophthalmic Res 2010;44:251-6.
114. Bharathi MJ, Ramakrishnan R, Meenakshi R, Mittal S, Shivakumar C,
Srinivasan M.
Microbiological diagnosis of infective keratitis: comparative evaluation of direct
microscopy and culture results.
Br J Ophthalmol 2006;90:1271-6.
115. Tananuvat N, Salakthuantee K, Vanittanakom N, Pongpom M, Ausayakhun
S.
Prospective comparison between conventional microbial work-up vs PCR in the
diagnosis of fungal keratitis.
Eye (Lond) 2012;26:1337-43.
116. Pickel J, Narayana S, Krishnan T, Ramakrishnan S, Samantaray PP, Porco
TC, et al.
The prognostic value of persistent culture positivity in fungal keratitis in the
mycotic antimicrobial localized injection trial.
Am J Ophthalmol 2020;215:1-7.
117. Krizsán K, Tóth E, Nagy LG, Galgóczy L, Manikandan P, Chandrasekaran M,
et al.
Molecular identification and antifungal susceptibility of Curvularia
australiensis, C. hawaiiensis and C. spicifera isolated from human eye
infections.
Mycoses 2015;58:603-9.
118. Zbiba W, Baba A, Bouayed E, Abdessalem N, Daldoul A.
A 5-year retrospective review of fungal keratitis in the region of Cap Bon.
J Fr Ophtalmol 2016;39:843-8.
119. Cheikh-Rouhou F, Makni F, Ayadi A, Ghorbel R, Ben Zina Z.
Parasitoses et mycoses oculaires: bilan des cas diagnostiqués dans le CHU de
Sfax entre 1996 et 1999.
Bull Soc Pathol Exot 2001;94:11-3.
120. Chongkae S, Youngchim S, Nosanchuk JD, Laliam A, Tangmonkongvoragul
C, Pruksaphon K.
Fungal Keratitis in Northern Thailand: spectrum of agents, risk factors and
putative virulence factors.
J Fungi (Basel) 2021;7:475.
121. Wang L, Han L, Yin W.
Study of pathogens of fungal keratitis and the sensitivity of pathogenic fungi to
therapeutic agents with the disk diffusion method.
Curr Eye Res 2015;40:1095-101.
122. Ting DSJ, Galal M, Kulkarni B, Elalfy MS, Lake D, Hamada S, et al.
Clinical characteristics and outcomes of fungal keratitis in the United Kingdom
2011-2020: a 10-year study.
J Fungi (Basel) 2021;7:966.
123. Sadik N, Elzeiny SM, Ali YE, Sobeih D.
Fungal keratitis in the Egyptian delta: epidemiology, risk factors, and
microbiological diagnosis.
Ophthalmic Epidemiol 2022;29:198-205.
124. Lalitha P, Shapiro BL, Srinivasan M, Prajna NV, Acharya NR, Fothergill AW,
et al.
Antimicrobial susceptibility of Fusarium, Aspergillus, and other filamentous
fungi isolated from keratitis.
Arch Ophthalmol 2007;125:789-93.
125. Pfaller MA, Diekema DJ.
Rare and emerging opportunistic fungal pathogens: concern for resistance
beyond Candida albicans and Aspergillus fumigatus.
J Clin Microbiol 2004;42:4419-31.
126. Meletiadis J, Geertsen E, Curfs-Breuker I, Meis JF, Mouton JW.
Intra- and interlaboratory agreement in assessing the in vitro activity of
micafungin against common and rare candida species with the EUCAST, CLSI,
and Etest Methods.
Antimicrob Agents Chemother 2016;60:6173-8.
127. Lalitha P, Prajna NV, Oldenburg CE, Srinivasan M, Krishnan T,
Mascarenhas J, et al.
Organism, minimum inhibitory concentration, and outcome in a fungal corneal
ulcer clinical trial.
Cornea 2012;31:662-7.
128. Shapiro BL, Lalitha P, Loh AR, Fothergill AW, Prajna NV, Srinivasan M, et
al.
Susceptibility testing and clinical outcome in fungal keratitis.
Br J Ophthalmol 2010;94:384-5.
129. Thomas PA, Abraham DJ, Kalavathy CM, Rajasekaran J.
Oral itraconazole therapy for mycotic keratitis.
Mycoses 1988;31:271-9.
130. Lakhani P, Patil A, Majumdar S.
Challenges in the Polyene- and Azole-based pharmacotherapy of ocular fungal
infections.
J Ocul Pharmacol Ther 2019;35:6-22.
131. Sav H, Rafati H, Öz Y, Dalyan-Cilo B, Ener B, Mohammadi F, et al.
Biofilm formation and resistance to fungicides in clinically relevant members of
the fungal genus fusarium.
J Fungi (Basel) 2018;4:16.
132. Sun S, Lyu Q, Han L, Ma Q, Hu H, He S, et al.
Molecular identification and in vitro susceptibility of Fusarium from fungal
keratitis in central China.
Zhonghua Yan Ke Za Zhi 2015;51:660-7.
133. Ranjith K, Sontam B, Sharma S, Joseph J, Chathoth KN, Sama KC, et al.
Candida species from eye infections: drug susceptibility, virulence factors, and
molecular characterization.
Invest Ophthalmol Vis Sci 2017;58:4201-9.
134. Oechsler RA, Yamanaka TM, Bispo PJ, Sartori J, Yu MC, Melo AS, et al.
Fusarium keratitis in Brazil: genotyping, in vitro susceptibilities, and clinical
outcomes.
Clin Ophthalmol 2013;7:1693-701.
135. Therese KL, Bagyalakshmi R, Madhavan HN, Deepa P.
In-vitro susceptibility testing by agar dilution method to determine the
minimum inhibitory concentrations of amphotericin B, fluconazole and
ketoconazole against ocular fungal isolates.
Indian J Med Microbiol 2006;24:273-9.
136. Morris AJ, McKinney WP, Rogers K, Freeman JT, Roberts SA.
Antifungal susceptibility of clinical mould isolates in New Zealand, 2001-2019.
Pathology 2021;53:639-44.
137. Shukla PK, Kumar M, Keshava GB.
Mycotic keratitis: an overview of diagnosis and therapy.
Mycoses 2008;51:183-99.
138. Ng JK, Fraunfelder FW, Winthrop KL.
Review and update on the epidemiology, clinical presentation, diagnosis, and
treatment of fungal keratitis.
Curr Fungal Infect Rep 2013;7:293-300.
139. Sha XY, Shi Q, Liu L, Zhong JX.
Update on the management of fungal keratitis.
Int Ophthalmol 2021;41:3249-56.
140. Aydin B, Cubuk MO, Ucgul A, Ertop M, Ozmen MC, Atalay T, et al.
Combined Intrastromal Voriconazole and Amphotericin B treatment for
persistent Fungal Keratitis.
Eye Contact Lens 2020;46:269-73.
141. Sharma N, Sankaran P, Agarwal T, Arora T, Chawla B, Titiyal JS, et al.
Evaluation of Intracameral Amphotericin B in the management of Fungal
Keratitis: randomized controlled trial.
Ocul Immunol Inflamm 2016;24:493-7.
142. Austin A, Lietman T, Rose-Nussbaumer J.
Update on the management of infectious keratitis.
Ophthalmology 2017;124:1678-89.
143. Prajna NV, Krishnan T, Mascarenhas J, Rajaraman R, Prajna L, Srinivasan
M, et al.
The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs
voriconazole.
JAMA Ophthalmol 2013;131:422-9.
144. Shah KB, Wu TG, Wilhelmus KR, Jones DB.
Activity of voriconazole against corneal isolates of Scedosporium
apiospermum.
Cornea 2003;22:33-6.